A highly-mutated coronavirus variant seems to only be spreading slowly so far
Scientists are keeping an eye on a coronavirus variant, known as C.1.2, that was first detected in South Africa in May because it has characteristics similar to other mutated forms of the virus that have become more transmissible. A study also found that it is further away from the original COVID-19 strain than any other variant. For now, though, researchers aren't panicking.
The World Health Organization on Tuesday said the variant "does not appear to be increasing in circulation," and the National Institute for Communicable Diseases in South Africa said that while C.1.2 has been detected in all nine of the country's provinces (as well as a few other places around the world), it's only been detected at a low rate. Per Forbes, the variant made up just 1 percent of all sequenced cases in South Africa in June. That did rise to 3 percent in July, but the more famous Delta variant still appears to be quite dominant, accounting for 67 percent and 89 percent of South African infections in June and July, respectively.
In fact, Delta may be one of the things that prevents C.1.2 from becoming a greater concern. "C.1.2 would have to be pretty good, pretty fit, and pretty fast to outcompete Delta at this stage," Dr. Megan Steain, a virologist at the University of Sydney's Central Clinical School, told The Guardian. "I think we're still very much at a point where this could die out, the prevalence is really low."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Still, scientists and health agencies like the WHO will continue to monitor the variant. Read more at The Guardian and Forbes.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Parker Palm Springs review: decadence in the California desert
The Week Recommends This over-the-top hotel is a mid-century modern gem
By Catherine Garcia, The Week US Published
-
The real story behind the Stanford Prison Experiment
The Explainer 'Everything you think you know is wrong' about Philip Zimbardo's infamous prison simulation
By Tess Foley-Cox Published
-
Is it safe for refugees to return to Syria?
Talking Point European countries rapidly froze asylum claims after Assad's fall but Syrian refugees may have reason not to rush home
By Richard Windsor, The Week UK Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published